Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury
about
New Prognostic Biomarkers in Patients With Traumatic Brain InjuryEarly Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature MouseSelective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injuryEthyl pyruvate protects against blood-brain barrier damage and improves long-term neurological outcomes in a rat model of traumatic brain injuryThe tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humansPathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy.MMP-9 inhibitor SB-3CT attenuates behavioral impairments and hippocampal loss after traumatic brain injury in rat.Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice.Differential regulation of matrix-metalloproteinases and their tissue inhibitors in patients with aneurysmal subarachnoid hemorrhage.Transcriptomic analysis of the effects of a fish oil enriched diet on murine brains.Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury.Feasibility and safety of intrathecal transplantation of autologous bone marrow mesenchymal stem cells in horses.The effect of progesterone dose on gene expression after traumatic brain injuryDelayed progression of edema formation around a hematoma expressing high levels of VEGF and mmp-9 in a patient with traumatic brain injury: case report.Melatonin Preserves Blood-Brain Barrier Integrity and Permeability via Matrix Metalloproteinase-9 Inhibition.Distinct roles of trauma and transfusion in induction of immune modulation after injury.Matrix Metalloproteinase Expression in Contusional Traumatic Brain Injury: A Paired Microdialysis Study.A blood-based biomarker panel to risk-stratify mild traumatic brain injury.Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study.Matrix metalloproteinase 9 and cellular fibronectin plasma concentrations are predictors of the composite endpoint of length of stay and death in the intensive care unit after severe traumatic brain injury.Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels.Circulating matrix metalloproteinases in children with diabetic ketoacidosis.The potential utility of blood-derived biochemical markers as indicators of early clinical trends following severe traumatic brain injury.The 70 kDa heat shock protein protects against experimental traumatic brain injuryAlterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice.MMP-3 Deficiency Alleviates Endotoxin-Induced Acute Inflammation in the Posterior Eye Segment.Molecular contributions to neurovascular unit dysfunctions after brain injuries: lessons for target-specific drug development.Correlations between blood-brain barrier disruption and neuroinflammation in an experimental model of penetrating ballistic-like brain injury.Effect of dexamethasone administered with magnesium sulfate on inflammation-mediated degradation of the blood-brain barrier using an in vitro model.Intracranial hemorrhage: mechanisms of secondary brain injury.Neurological diseases in relation to the blood-brain barrier.Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury.Matrix metalloproteinase-9 involvement in the structural plasticity of dendritic spines.Time dependent integration of matrix metalloproteinases and their targeted substrates directs axonal sprouting and synaptogenesis following central nervous system injury.Pathogenesis of brain edema and investigation into anti-edema drugs.MMP-9 in translation: from molecule to brain physiology, pathology, and therapy.Carprofen inhibits the release of matrix metalloproteinases 1, 3, and 13 in the secretome of an explant model of articular cartilage stimulated with interleukin 1β.Degradomics in Neurotrauma: Profiling Traumatic Brain Injury.Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury.Vascular inter-regulation of inflammation: molecular and cellular targets for CNS therapy.
P2860
Q26768672-E6B64BC8-5579-48F2-8CE8-127825E29751Q27340373-380ECB4A-3368-4926-AE3E-19BCB10A1121Q28534597-1A52851A-2892-4ED2-AB58-F5D20511DBB0Q28651196-5E04C6BE-5B4D-4DA7-8EC0-6180BDD9EDE1Q30528502-E1A48A57-FB96-4B63-A016-462D56C52C31Q33742612-7FCDD4FE-DF67-4CBA-A0EA-5CDD8BF1708EQ33847555-3BEE27F5-96BD-4FA8-B739-314F534ADD0BQ34422275-67A444E0-02A6-4B35-8CAF-0E0BBBE84D90Q34652720-76973CDA-4A69-4130-B063-073CCC9A05EAQ35121792-0331C831-7DD8-4AFC-8275-37A0D989D34FQ35146718-78A9E111-C39C-40EA-80BA-087514B5D5FAQ35204364-6F416B86-95D7-46BA-AE42-9D38FE3AF30CQ35212550-7F366D56-1640-4B1B-9DD2-BD1FB9F7B150Q35869351-5AF3D544-AEBE-4069-915B-FEC682624E83Q36010456-6C3E9987-40AB-4D21-9228-5DBC039DA7C1Q36084211-2C0136A9-58F1-4EBA-80AD-F6F9ACE231F4Q36123018-BD6BC939-DD8C-4CFC-A3F3-9A484FD8712BQ36326665-B030F170-ED4C-4B59-8DF7-D7963D41E3E6Q36381738-C60BA920-3EC5-4239-8B30-8CD8FECC5928Q36604205-6B54B300-B78D-4B6D-AED2-51B52C34680CQ36996481-9EFC43D4-0ADC-4B0C-8010-2E2ED9E64DD8Q37153161-F53E52A5-8F76-443C-AED2-D7D0FBE1241EQ37154481-3CE675DC-46BB-4246-B6A6-36D3F9FEBB8FQ37237873-5E5201C3-EF87-4514-BD25-F86111EBE1E9Q37249700-BAF0BFD1-4E69-4017-9E1B-4AA624B34A14Q37465463-1E176692-2612-4F1D-8BBF-734DA2BA6C8BQ37523317-0B0140A6-09E0-4AC8-83C8-4F02F84F3314Q37602942-55579883-23B7-4B35-BD30-2B7B289856E0Q37651320-FBF18257-1C7D-4777-996E-03B12D02CD71Q37897166-81C6D284-8FA6-4BCB-934F-FD32B5565DF3Q37976564-FE32F843-AE39-4C72-B97D-80075D4EBA59Q38215270-1DEE344A-1063-4CAF-A4C1-B21311359018Q38234888-D03B0952-9DFD-4884-A356-21370427A7E0Q38248004-9A9F96A0-6E6D-483C-97F4-8549D382E8AFQ38459572-5275A824-5B01-466D-8EC3-7F9307BB2C6BQ38622769-A00EAD22-721F-49BA-8A7C-3D2C78793F04Q38650698-3953683E-DA0C-4F34-AC18-5081D367121AQ38784171-0392791C-9EC7-464B-9640-9C4C06D07108Q38846432-70A0D40F-EADD-4064-99BD-3D56466CD068Q39031301-8797B691-25C6-4625-A795-C271CCD14C79
P2860
Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Elevation of matrix metallopro ...... severe traumatic brain injury
@en
Elevation of matrix metallopro ...... severe traumatic brain injury.
@nl
type
label
Elevation of matrix metallopro ...... severe traumatic brain injury
@en
Elevation of matrix metallopro ...... severe traumatic brain injury.
@nl
prefLabel
Elevation of matrix metallopro ...... severe traumatic brain injury
@en
Elevation of matrix metallopro ...... severe traumatic brain injury.
@nl
P2093
P2860
P921
P1433
P1476
Elevation of matrix metallopro ...... severe traumatic brain injury
@en
P2093
Gary A Rosenberg
Howard Yonas
Jeremy Phelps
Mark Grossetete
P2860
P304
P356
10.1227/01.NEU.0000351768.11363.48
P407
P50
P577
2009-10-01T00:00:00Z